We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $417M
1-Year Est. Return 25.02%
This Fund
S&P 500
This Quarter Est. Return
+8.33%
1 Year Est. Return
+25.02%
3 Year Est. Return
+98.12%
5 Year Est. Return
+139.29%
10 Year Est. Return
+812.75%
AUM
$481M
AUM Growth
+$18.7M
Cap. Flow
-$10M
Cap. Flow %
-2.08%
Top 10 Hldgs %
74.53%
Holding
46
New
Increased
4
Reduced
34
Closed
7

Top Buys

Rank Stock Value
1
GEV icon
GE Vernova
GEV
+$3.77M
2
PANW icon
Palo Alto Networks
PANW
+$140K
3
NOW icon
ServiceNow
NOW
+$92.6K
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$57.3K

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$3.68M
2
CMG icon
Chipotle Mexican Grill
CMG
+$3.23M
3
AAPL icon
Apple
AAPL
+$1.56M
4
JPM icon
JPMorgan Chase
JPM
+$809K
5
URGN icon
UroGen Pharma
URGN
+$692K

Sector Composition

Rank Sector Weight
1 Technology 45.26%
2 Consumer Discretionary 19.67%
3 Healthcare 16.62%
4 Communication Services 14.12%
5 Financials 2.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMG icon
26
Chipotle Mexican Grill
CMG
$42.6B
$1.58M 0.33%
42,642
-89,298
-68% -$3.23M
COST icon
27
Costco
COST
$422B
$1.2M 0.25%
1,392
-12
-0.9% -$10.9K
JNJ icon
28
Johnson & Johnson
JNJ
$641B
$692K 0.14%
3,344
-188
-5% -$37.2K
ABBV icon
29
AbbVie
ABBV
$454B
$630K 0.13%
2,758
-224
-8% -$51K
CAT icon
30
Caterpillar
CAT
$402B
$544K 0.11%
949
-75
-7% -$41.7K
MRK icon
31
Merck
MRK
$323B
$467K 0.1%
4,437
-375
-8% -$35.2K
DE icon
32
Deere & Co
DE
$169B
$425K 0.09%
912
-70
-7% -$32.9K
ABT icon
33
Abbott
ABT
$182B
$389K 0.08%
3,105
-960
-24% -$122K
ORCL icon
34
Oracle
ORCL
$345B
$383K 0.08%
1,964
-50
-2% -$11.9K
NUE icon
35
Nucor
NUE
$56.4B
$373K 0.08%
2,285
-140
-6% -$21K
GILD icon
36
Gilead Sciences
GILD
$162B
$346K 0.07%
2,819
V icon
37
Visa
V
$689B
$305K 0.06%
868
-136
-14% -$46.3K
AVGO icon
38
Broadcom
AVGO
$1.82T
$260K 0.05%
750
-25
-3% -$8.94K
DUK icon
39
Duke Energy
DUK
$100B
$205K 0.04%
1,748
-100
-5% -$12.2K
AEP icon
40
American Electric Power
AEP
$72.7B
-2,050
Closed -$231K
BCRX icon
41
BioCryst Pharmaceuticals
BCRX
$2.43B
-23,710
Closed -$180K
EOLS icon
42
Evolus
EOLS
$407M
-25,070
Closed -$154K
JPM icon
43
JPMorgan Chase
JPM
$947B
-2,565
Closed -$809K
PLSE icon
44
Pulse Biosciences
PLSE
$2.27B
-11,590
Closed -$205K
RSP icon
45
Invesco S&P 500 Equal Weight ETF
RSP
$97.1B
-1,274
Closed -$242K
URGN icon
46
UroGen Pharma
URGN
$2.02B
-34,701
Closed -$692K

Similar funds

Bender Robert & Associates's Q4 2025 Portfolio in Review

As of Q4 2025, Bender Robert & Associates held 46 positions worth $481M, up 4% from $463M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Bender Robert & Associates's Q4 2025 filing shows 4 increased, 34 reduced and 7 closed positions. The largest sale was NVIDIA, an estimated $3.68M.

By sector, the portfolio is most concentrated in Technology at 45% of assets, down from 47% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Bender Robert & Associates added most to GE Vernova in Q4 2025, an estimated $3.77M increase.
  • Bender Robert & Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.68M.
  • Bender Robert & Associates fully exited JPMorgan Chase in Q4 2025, selling an estimated $809K.
  • Bender Robert & Associates's ten largest holdings make up 75% of its $481M portfolio in Q4 2025.
  • Bender Robert & Associates opened 0 new positions and closed 7 in Q4 2025.
  • Bender Robert & Associates's portfolio value rose 4% quarter-over-quarter to $481M.

Based on Bender Robert & Associates's 13F filing for Q4 2025, filed 29 Jan 2026.